Latest GranuFlo Stories

Alert: Granuflo Allegedly Linked to Serious Health Risks Including Stroke, Heart Attack and Cardiopulmonary Arrest. Dallas, TX (PRWEB) May 08, 2013 The National Plaintiff’s Law Firm of Baron and Budd is now handling lawsuits pertaining to the recall of Granuflo, the brand name of a dialysate (http://www.fda.gov/medicaldevices/safety/listofrecalls/ucm309990.htm ). Dialysate is used when a patient undergoes dialysis, a long-term medical treatment used to treat kidney conditions....

The Firm is now evaluating GranuFlo recall lawsuits on behalf of dialysis patients who experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other alleged GranuFlo side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte. New York, New York (PRWEB) May 04, 2013 GranuFlo lawsuits filed in the wake of last year’s recall for GranuFlo and NaturaLyte dialysis concentrates continue to mount in state and federal courts throughout the country,...

The Firm is offering GranuFlo heart attack lawsuit evaluations to dialysis patients who allegedly experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) April 01, 2013 Court documents indicate that a panel of federal judges has agreed to consolidate all GranuFlo lawsuits stemming from the recent recall of GranuFlo or NaturaLyte...

The Firm is offering GranuFlo recall lawsuit evaluations to dialysis patients who experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) March 15, 2013 As GranuFlo lawsuits related to Fresenius’ recent recall of GranuFlo and NaturaLyte dialysis concentrates continue to mount, the company is facing more problems with the U.S. Food...

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, GranuFlo Recall Help (http://www.granuflorecallhelp.com/). The Food and Drug Administration issued a Class 1 recall of all GranuFlo and NaturaLyte dialysis products after the dialysate acid concentrates were linked to severe complications such as heart attack, stroke and sudden cardiac death. Austin, Texas (PRWEB) January 21, 2013 The law firm of Hissey Kientz, LLP is announcing the launch of its new website,...

Bernstein Liebhard LLP continues to evaluate GranuFlo lawsuits on behalf of dialysis patients who experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other serious heart complication allegedly caused by GranuFlo and NaturaLyte dialysis products. New York, New York (PRWEB) January 12, 2013 Fresenius Medical Care, the maker of GranuFlo and NaturaLyte dialysis products, supports the consolidation of all federally-filed GranuFlo lawsuits in a multidistrict litigation...

Reich & Binstock, LLP is currently investigating claims against Fresenius Medical Care AG, the makers of dialysis products GranuFlo® and NaturaLyte®. These products have been linked to causing alkalosis, a condition associated with an increase in cardiovascular death and catastrophic cardiovascular injuries in patients undergoing dialysis. Houston, Texas (PRWEB) October 10, 2012 Reich & Binstock, LLP, a Houston-based law firm, is currently investigating claims against...

Ennis & Ennis, P.A. Announces Free Nationwide Consultations for Patients Affected by Fresenius' Naturalyte and GranuFlo Recall (PRWEB) July 18, 2012 On June 27, 2012, the FDA issued a recall for Fresenius Medical Care North America's dialysis products, Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate, due to a risk of potentially fatal serum bicarbonate levels. Naturalyte Liquid and Naturalyte GranuFlo are dialysis products. On November...

Parker Waichman is now advising that the FDA has issued a Class I Recall for GranuFlo and NaturaLyte Dialysis Products manufactured by Fresenius Medical Care. This FDA Action Follows Revelation that Over 900 Patients Suffered Cardiac Arrest at Fresenius Dialysis Clinics in 2010. According to the company, GranuFlo and NaturaLyte are Associated with Elevated Bicarbonate Levels, a Significant Risk Factor for Cardiac Arrest. New York, New York (PRWEB) June 28, 2012 Parker Waichman LLP, a...